Filing Flows › Emmaus Life Sciences (EMMA) › How it makes money
How Emmaus Life Sciences (EMMA) makes money
Emmaus Life Sciences (EMMA) made $6.3M of revenue in the second quarter 2026 (Q2 2026), +124% from a year earlier. Endari US brought in $6.0M (95%); Endari International brought in $295K (5%); Product and Service Other brought in $22K (0%). Of every dollar of revenue, 95¢ was left as gross profit, 60¢ was left as operating profit, 21¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q2 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Endari US | $6.0M | 95.0% | +336% | +158% |
| Endari International | $295K | 4.7% | -49% | -38% |
| Product and Service Other | $22K | 0.3% | -4% | +10% |
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $6.3M | 100.0% |
| Cost of revenue | $344K | 5.4% |
| Gross profit | $6.0M | 94.6% |
| Operating expenses | $2.2M | 34.6% |
| Operating profit | $3.8M | 60.0% |
| Net earnings | $1.3M | 21.2% |
| Operating cash flow | $1.7M | 26.8% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $6.3M | +124% |
| Q1 2026 | $2.0M | -18% |
| Q4 2025 | $3.9M | +17% |
| Q3 2025 | $3.4M | -38% |
| Q2 2025 | $2.8M | -48% |
| Q1 2025 | $2.4M | -4% |
| Q4 2024 | $3.3M | -53% |
From Emmaus Life Sciences' 10-Q filed Aug 14, 2026 (on EDGAR).
Questions
How does Emmaus Life Sciences make money?
Emmaus Life Sciences (EMMA) made $6.3M of revenue in the second quarter 2026 (Q2 2026), +124% from a year earlier. Endari US brought in $6.0M (95%); Endari International brought in $295K (5%); Product and Service Other brought in $22K (0%). Of every dollar of revenue, 95¢ was left as gross profit, 60¢ was left as operating profit, 21¢ was left as net earnings.
What is Emmaus Life Sciences' biggest business?
Endari US: $6.0M in the second quarter 2026, 95% of revenue, +158% from a year earlier.
What is Emmaus Life Sciences' profit margin?
Net earnings were $1.3M, 21.2% of revenue, in the second quarter 2026; the operating margin was 60.0%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.